SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001437749-20-017080
Filing Date
2020-08-07
Accepted
2020-08-07 16:12:12
Documents
46
Period of Report
2020-06-30

Document Format Files

Seq Description Document Type Size
1 FORM 10-Q dffn20200630_10q.htm 10-Q 610369
2 EXHIBIT 31.1 ex_197103.htm EX-31.1 10494
3 EXHIBIT 31.2 ex_197104.htm EX-31.2 10508
4 EXHIBIT 32.1 ex_197105.htm EX-32.1 5131
5 EXHIBIT 32.2 ex_197106.htm EX-32.2 5024
  Complete submission text file 0001437749-20-017080.txt   2798827

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE DOCUMENT dffn-20200630.xml EX-101.INS 470702
7 XBRL TAXONOMY EXTENSION SCHEMA dffn-20200630.xsd EX-101.SCH 33721
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE dffn-20200630_cal.xml EX-101.CAL 23622
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE dffn-20200630_def.xml EX-101.DEF 193422
10 XBRL TAXONOMY EXTENSION LABEL LINKBASE dffn-20200630_lab.xml EX-101.LAB 201732
11 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE dffn-20200630_pre.xml EX-101.PRE 213066
Mailing Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902
Business Address 2020 AVON COURT SUITE 4 CHARLOTTESVILLE VA 22902 (434) 220-0718
Diffusion Pharmaceuticals Inc. (Filer) CIK: 0001053691 (see all company filings)

IRS No.: 300645032 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-37942 | Film No.: 201085312
SIC: 2834 Pharmaceutical Preparations